People Are Already Taking This Unapproved New Weight-Loss Drug

December 12, 2025

•

1 min read

•

WIRED

Retatrutide, originally developed by Eli Lilly, has found a loyal fan base—even though clinical trials of the drug still haven’t finished.

Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid. A Viral C... [2142 chars]

Read Original Article

Source: WIRED

Visit Source

Share this article

Twitter Facebook

Back to business news